-
1
-
-
0034025706
-
Growth hormone and colorectal carcinoma: Localization of receptors
-
[PMID: 10757060]
-
Lincoln DT, Kaiser HE, Raju GP, Waters MJ. Growth hormone and colorectal carcinoma: localization of receptors. In Vivo 2000; 14: 41-49 [PMID: 10757060]
-
(2000)
In Vivo
, vol.14
, pp. 41-49
-
-
Lincoln, D.T.1
Kaiser, H.E.2
Raju, G.P.3
Waters, M.J.4
-
2
-
-
26944493862
-
Model for growth hormone receptor activation based on subunit rotation within a receptor dimer
-
[PMID: 16116438 DOI: 10.1038/nsmb977]
-
Brown RJ, Adams JJ, Pelekanos RA, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW, Waters MJ. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 2005; 12: 814-821 [PMID: 16116438 DOI: 10.1038/nsmb977]
-
(2005)
Nat Struct Mol Biol
, vol.12
, pp. 814-821
-
-
Brown, R.J.1
Adams, J.J.2
Pelekanos, R.A.3
Wan, Y.4
McKinstry, W.J.5
Palethorpe, K.6
Seeber, R.M.7
Monks, T.A.8
Eidne, K.A.9
Parker, M.W.10
Waters, M.J.11
-
3
-
-
0037183320
-
Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: A cohort study
-
[PMID: 12147369 DOI: 10.1016/S0140-6736(02)09519-3]
-
Swerdlow AJ, Higgins CD, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 2002; 360: 273-277 [PMID: 12147369 DOI: 10.1016/S0140-6736(02)09519-3]
-
(2002)
Lancet
, vol.360
, pp. 273-277
-
-
Swerdlow, A.J.1
Higgins, C.D.2
Adlard, P.3
Preece, M.A.4
-
4
-
-
0038359743
-
Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform
-
[PMID: 12679461 DOI: 10.1210/ jc.2002-021667]
-
Pantel J, Grulich-Henn J, Bettendorf M, Strasburger CJ, Heinrich U, Amselem S. Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform. J Clin Endocrinol Metab 2003; 88: 1705-1710 [PMID: 12679461 DOI: 10.1210/ jc.2002-021667]
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 1705-1710
-
-
Pantel, J.1
Grulich-Henn, J.2
Bettendorf, M.3
Strasburger, C.J.4
Heinrich, U.5
Amselem, S.6
-
5
-
-
0037014743
-
Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer
-
[PMID: 12096082 DOI: 10.1093/jnci/94.13.972]
-
Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002; 94: 972-980 [PMID: 12096082 DOI: 10.1093/jnci/94.13.972]
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 972-980
-
-
Sandhu, M.S.1
Dunger, D.B.2
Giovannucci, E.L.3
-
6
-
-
0037398468
-
Degree of fatness after treatment of malignant lymphoma in childhood
-
[PMID: 12555252 DOI: 10.1002/mpo.10260]
-
Nysom K, Holm K, Michaelsen KF, Hertz H, Müller J, Mølgaard C. Degree of fatness after treatment of malignant lymphoma in childhood. Med Pediatr Oncol 2003; 40: 239-243 [PMID: 12555252 DOI: 10.1002/mpo.10260]
-
(2003)
Med Pediatr Oncol
, vol.40
, pp. 239-243
-
-
Nysom, K.1
Holm, K.2
Michaelsen, K.F.3
Hertz, H.4
Müller, J.5
Mølgaard, C.6
-
7
-
-
0034657348
-
The role of STAT proteins in growth hormone signaling
-
[PMID: 10851057 DOI: 10.1038/sj.onc.1203526]
-
Herrington J, Smit LS, Schwartz J, Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene 2000; 19: 2585-2597 [PMID: 10851057 DOI: 10.1038/sj.onc.1203526]
-
(2000)
Oncogene
, vol.19
, pp. 2585-2597
-
-
Herrington, J.1
Smit, L.S.2
Schwartz, J.3
Carter-Su, C.4
-
8
-
-
33244480332
-
New insights into growth hormone action
-
[PMID: 16461922 DOI: 10.1677/jme.1.01933]
-
Waters MJ, Hoang HN, Fairlie DP, Pelekanos RA, Brown RJ. New insights into growth hormone action. J Mol Endocrinol 2006; 36: 1-7 [PMID: 16461922 DOI: 10.1677/jme.1.01933]
-
(2006)
J Mol Endocrinol
, vol.36
, pp. 1-7
-
-
Waters, M.J.1
Hoang, H.N.2
Fairlie, D.P.3
Pelekanos, R.A.4
Brown, R.J.5
-
9
-
-
33847376775
-
Growth hormone treatment and cancer risk
-
[PMID: 17336744 DOI: 10.1016/j.ecl.2006.11.007]
-
Banerjee I, Clayton PE. Growth hormone treatment and cancer risk. Endocrinol Metab Clin North Am 2007; 36: 247-263 [PMID: 17336744 DOI: 10.1016/j.ecl.2006.11.007]
-
(2007)
Endocrinol Metab Clin North Am
, vol.36
, pp. 247-263
-
-
Banerjee, I.1
Clayton, P.E.2
-
10
-
-
0037169829
-
Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: New insights into signaling pathways
-
[PMID: 11911939 DOI: 10.1016/S0303-7207(02)00014-X]
-
Jeay S, Sonenshein GE, Postel-Vinay MC, Kelly PA, Baixeras E. Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways. Mol Cell Endocrinol 2002; 188: 1-7 [PMID: 11911939 DOI: 10.1016/S0303-7207(02)00014-X]
-
(2002)
Mol Cell Endocrinol
, vol.188
, pp. 1-7
-
-
Jeay, S.1
Sonenshein, G.E.2
Postel-Vinay, M.C.3
Kelly, P.A.4
Baixeras, E.5
-
11
-
-
33746906218
-
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth
-
[PMID: 16541323 DOI: 10.1007/s10549-006-9168-1]
-
Divisova J, Kuiatse I, Lazard Z, Weiss H, Vreeland F, Hadsell DL, Schiff R, Osborne CK, Lee AV. The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth. Breast Cancer Res Treat 2006; 98: 315-327 [PMID: 16541323 DOI: 10.1007/s10549-006-9168-1]
-
(2006)
Breast Cancer Res Treat
, vol.98
, pp. 315-327
-
-
Divisova, J.1
Kuiatse, I.2
Lazard, Z.3
Weiss, H.4
Vreeland, F.5
Hadsell, D.L.6
Schiff, R.7
Osborne, C.K.8
Lee, A.V.9
-
12
-
-
0036725771
-
Blocking oncogenes in malignant cells by RNA interference--new hope for a highly specific cancer treatment?
-
[PMID: 12242146 DOI: 10.1016/S1535-6108(02)00129-0]
-
Borkhardt A. Blocking oncogenes in malignant cells by RNA interference--new hope for a highly specific cancer treatment? Cancer Cell 2002; 2: 167-168 [PMID: 12242146 DOI: 10.1016/S1535-6108(02)00129-0]
-
(2002)
Cancer Cell
, vol.2
, pp. 167-168
-
-
Borkhardt, A.1
-
13
-
-
4243754537
-
Confirming specificity of RNAi in mammalian cells
-
[PMID: 12198178 DOI: 10.1126/scisignal.1472002pl13]
-
Lassus P, Rodriguez J, Lazebnik Y. Confirming specificity of RNAi in mammalian cells. Sci STKE 2002; 2002: pl13 [PMID: 12198178 DOI: 10.1126/scisignal.1472002pl13]
-
(2002)
Sci STKE
, vol.2002
, pp. 13
-
-
Lassus, P.1
Rodriguez, J.2
Lazebnik, Y.3
-
14
-
-
67650874081
-
Cancer statistics, 2009
-
[PMID: 19474385 DOI: 10.3322/caac.20006]
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249 [PMID: 19474385 DOI: 10.3322/caac.20006]
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
15
-
-
40749149728
-
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial
-
[PMID: 18358928 DOI: 10.1016/S0140-6736(08)60455-9]
-
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, FinchJones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-1016 [PMID: 18358928 DOI: 10.1016/S0140-6736(08)60455-9]
-
(2008)
Lancet
, vol.371
, pp. 1007-1016
-
-
Nordlinger, B.1
Sorbye, H.2
Glimelius, B.3
Poston, G.J.4
Schlag, P.M.5
Rougier, P.6
Bechstein, W.O.7
Primrose, J.N.8
Walpole, E.T.9
Finchjones, M.10
Jaeck, D.11
Mirza, D.12
Parks, R.W.13
Collette, L.14
Praet, M.15
Bethe, U.16
van Cutsem, E.17
Scheithauer, W.18
Gruenberger, T.19
-
16
-
-
34250902061
-
Gene expression profiling in sarcomas
-
[PMID: 17555981 DOI: 10.1016/ j.critrevonc.2007.04.001]
-
Tschoep K, Kohlmann A, Schlemmer M, Haferlach T, Issels RD. Gene expression profiling in sarcomas. Crit Rev Oncol Hematol 2007; 63: 111-124 [PMID: 17555981 DOI: 10.1016/ j.critrevonc.2007.04.001]
-
(2007)
Crit Rev Oncol Hematol
, vol.63
, pp. 111-124
-
-
Tschoep, K.1
Kohlmann, A.2
Schlemmer, M.3
Haferlach, T.4
Issels, R.D.5
-
17
-
-
0037308230
-
Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: A positive study
-
[PMID: 12557135 DOI: 10.1053/gast.2003.50057]
-
Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 2003; 124: 293-302 [PMID: 12557135 DOI: 10.1053/gast.2003.50057]
-
(2003)
Gastroenterology
, vol.124
, pp. 293-302
-
-
Seguy, D.1
Vahedi, K.2
Kapel, N.3
Souberbielle, J.C.4
Messing, B.5
-
18
-
-
33847392443
-
Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: Implications for cancer therapy
-
[PMID: 17289896 DOI: 10.1158/1078-0432.CCR-06-1910]
-
Yin D, Vreeland F, Schaaf LJ, Millham R, Duncan BA, Sharma A. Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy. Clin Cancer Res 2007; 13: 1000-1009 [PMID: 17289896 DOI: 10.1158/1078-0432.CCR-06-1910]
-
(2007)
Clin Cancer Res
, vol.13
, pp. 1000-1009
-
-
Yin, D.1
Vreeland, F.2
Schaaf, L.J.3
Millham, R.4
Duncan, B.A.5
Sharma, A.6
-
19
-
-
33645022208
-
Does growth hormone cause cancer?
-
[PMID: 16430706 DOI: 10.1111/j.1365-2265.2005.02404.x]
-
Jenkins PJ, Mukherjee A, Shalet SM. Does growth hormone cause cancer? Clin Endocrinol (Oxf) 2006; 64: 115-121 [PMID: 16430706 DOI: 10.1111/j.1365-2265.2005.02404.x]
-
(2006)
Clin Endocrinol (Oxf)
, vol.64
, pp. 115-121
-
-
Jenkins, P.J.1
Mukherjee, A.2
Shalet, S.M.3
-
20
-
-
0034773409
-
Expression of the insulin-like growth factors (IGFs) and the IGFbinding proteins (IGFBPs) in human gastric cancer cells
-
[PMID: 11677116 DOI: 10.1016/ S0959-8049(01)00269-6]
-
Yi HK, Hwang PH, Yang DH, Kang CW, Lee DY. Expression of the insulin-like growth factors (IGFs) and the IGFbinding proteins (IGFBPs) in human gastric cancer cells. Eur J Cancer 2001; 37: 2257-2263 [PMID: 11677116 DOI: 10.1016/ S0959-8049(01)00269-6]
-
(2001)
Eur J Cancer
, vol.37
, pp. 2257-2263
-
-
Yi, H.K.1
Hwang, P.H.2
Yang, D.H.3
Kang, C.W.4
Lee, D.Y.5
-
21
-
-
33745324588
-
Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy
-
[PMID: 16516462 DOI: 10.1016/j.ejca.2005.12.012]
-
Wu X, Wan M, Li G, Xu Z, Chen C, Liu F, Li J. Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy. Eur J Cancer 2006; 42: 888-894 [PMID: 16516462 DOI: 10.1016/j.ejca.2005.12.012]
-
(2006)
Eur J Cancer
, vol.42
, pp. 888-894
-
-
Wu, X.1
Wan, M.2
Li, G.3
Xu, Z.4
Chen, C.5
Liu, F.6
Li, J.7
-
22
-
-
34548087567
-
Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis
-
[PMID: 17690250 DOI: 10.1073/pnas.0600181104]
-
Conway-Campbell BL, Wooh JW, Brooks AJ, Gordon D, Brown RJ, Lichanska AM, Chin HS, Barton CL, Boyle GM, Parsons PG, Jans DA, Waters MJ. Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis. Proc Natl Acad Sci USA 2007; 104: 13331-13336 [PMID: 17690250 DOI: 10.1073/pnas.0600181104]
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 13331-13336
-
-
Conway-Campbell, B.L.1
Wooh, J.W.2
Brooks, A.J.3
Gordon, D.4
Brown, R.J.5
Lichanska, A.M.6
Chin, H.S.7
Barton, C.L.8
Boyle, G.M.9
Parsons, P.G.10
Jans, D.A.11
Waters, M.J.12
-
23
-
-
0036797073
-
Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer
-
[PMID: 12379772]
-
Reinmuth N, Fan F, Liu W, Parikh AA, Stoeltzing O, Jung YD, Bucana CD, Radinsky R, Gallick GE, Ellis LM. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 2002; 82: 1377-1389 [PMID: 12379772]
-
(2002)
Lab Invest
, vol.82
, pp. 1377-1389
-
-
Reinmuth, N.1
Fan, F.2
Liu, W.3
Parikh, A.A.4
Stoeltzing, O.5
Jung, Y.D.6
Bucana, C.D.7
Radinsky, R.8
Gallick, G.E.9
Ellis, L.M.10
-
24
-
-
34250379038
-
RNAi gene silencing using cerasome as a viral-size siRNA-carrier free from fusion and cross-linking
-
[PMID: 17502138 DOI: 10.1016/ j.bmcl.2007.04]
-
Matsui K, Sasaki Y, Komatsu T, Mukai M, Kikuchi J, Aoyama Y. RNAi gene silencing using cerasome as a viral-size siRNA-carrier free from fusion and cross-linking. Bioorg Med Chem Lett 2007; 17: 3935-3938 [PMID: 17502138 DOI: 10.1016/ j.bmcl.2007.04]
-
(2007)
Bioorg Med Chem Lett
, vol.17
, pp. 3935-3938
-
-
Matsui, K.1
Sasaki, Y.2
Komatsu, T.3
Mukai, M.4
Kikuchi, J.5
Aoyama, Y.6
-
25
-
-
0038047685
-
AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t (8; 21)-positive leukemic cells
-
[PMID: 12480707 DOI: 10.1182/ blood-2002-05-1589]
-
Heidenreich O, Krauter J, Riehle H, Hadwiger P, John M, Heil G, Vornlocher HP, Nordheim A. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t (8; 21)-positive leukemic cells. Blood 2003; 101: 3157-3163 [PMID: 12480707 DOI: 10.1182/ blood-2002-05-1589]
-
(2003)
Blood
, vol.101
, pp. 3157-3163
-
-
Heidenreich, O.1
Krauter, J.2
Riehle, H.3
Hadwiger, P.4
John, M.5
Heil, G.6
Vornlocher, H.P.7
Nordheim, A.8
|